Skip to main content

Articles

Practice Management
Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
Stakeholder Perspective
Is It Time for Risk-Sharing Contracts In Specialty Pharmacy?
Read More
Original Research
Diagnosis and Treatment of Bipolar Disorders in Adults: A Review of the Evidence on Pharmacologic Treatments
Stakeholder Perspective
Bipolar Disorders: Balancing Formulary Management and Clinical Outcomes for a Vulnerable Patient Population
Read More
Correction
Read More
A Multistakeholder Approach to Improving Quality in Rheumatoid Arthritis
Read More
Lowering Costs Through Effective Hematologic Malignancy Diagnosis
Read More
Perspectives
Read All About It
Read More
Introduction
Cardiometabolic Health in 2014: Clinical and Economic Implications
Read More
Practice Management
Impact of the New ACC/AHA Guidelines on the Treatment of High Blood Cholesterol in a Managed Care Setting
Stakeholder Perspective
Real-World Consequences of the 2013 ACC/AHA Cholesterol Guidelines for the Prevention of Cardiovascular Disease
Read More
Original Research
Utilization of Parenteral Anticoagulants and Warfarin: Impact on the Risk of Venous Thromboembolism Recurrence in the Outpatient Setting
Stakeholder Perspective
Better Compliance with Clinical Guidelines for Venous Thromboembolism Can Improve Patient Outcomes, Reduce Costs
Read More
Original Research
New and Emerging Drugs and Targets for Type 2 Diabetes: Reviewing the Evidence
Stakeholder Perspective
Addressing Adherence a Key Challenge in the Management of Patients with Type 2 Diabetes
Read More
Page 142 of 244
Results 1411 - 1420 of 2434